A new plan to force hospitals to report adverse effects of ‘natural health products’ such as herbal remedies and supplements has come as a surprise to manufacturers
The hospital’s chief executive, Norbert Pfeiffer, said the surgeon wrongly decided to go ahead with the routine procedure even though no qualified assistant was available.
AbCellera Biologics is announcing a new $700-million project today that will add research and development capacity to the manufacturing plant that has been in the works since 2020.